Farther Finance Advisors’s Dyne Therapeutics DYN Stock Holding History

Farther Finance Advisors’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$822	Buy	51 +31	+155%	+$712	﹤0.01%	5639
2026 Q2	$444	Sell	20 -4	-17%	-$74	﹤0.01%	5559
2026 Q1	$434	Buy	24 +7	+41%	+$121	﹤0.01%	5300
2025 Q4	$333	Buy	17 +2	+13%	+$38	﹤0.01%	5113
2025 Q3	$190	Buy	+15	New	+$171	﹤0.01%	4728
2025 Q1	–	Sell	-3	Closed	-$71	–	4303
2024 Q4	$71	Hold	3	–	–	﹤0.01%	3837
2024 Q3	$108	Buy	+3	New	+$119	﹤0.01%	3768

Other funds holding DYN

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's DYN Position: Q3 2026 in Review

Farther Finance Advisors increased its Dyne Therapeutics (DYN) stake by 155% in Q3 2026, buying an estimated $712 and bringing the position to 51 shares worth $822. The position accounts for ﹤0.01% of the portfolio, ranked #5639.

Farther Finance Advisors first reported a position in DYN in Q3 2024 and has held it in 7 quarters since. 4 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

Farther Finance Advisors held 51 shares of Dyne Therapeutics worth $822 as of Q3 2026.
Farther Finance Advisors bought 31 Dyne Therapeutics shares in Q3 2026, an estimated $712.
Dyne Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5639 holding.
Farther Finance Advisors first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 7 quarters since.
4 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.